{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:43:13Z","timestamp":1787024593872,"version":"build-2736575974"},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,2,15]]},"DOI":"10.2169\/internalmedicine.1707-23","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T18:11:53Z","timestamp":1687889513000},"page":"513-519","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Response of Primary Malignant Pericardial Mesothelioma with Peritoneal Dissemination to Nivolumab"],"prefix":"10.2169","volume":"63","author":[{"given":"Shun","family":"Fujiwara","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Kano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), Japan"},{"name":"Department of Clinical Oncology, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Maejima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Fujioka","sequence":"additional","affiliation":[{"name":"Department of Radiology, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Kirimura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Miyake","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Tokyo Medical and Dental University (TMDU), Japan"},{"name":"Department of Palliative Care, Tsuchiura Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nilsson A, Rasmuson T. Primary pericardial mesothelioma: report of a patient and literature review. Case Rep Oncol 2: 125-132, 2009.","DOI":"10.1159\/000228894"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gemba K, Fujimoto N, Kato K, et al. National survey of malignant mesothelioma and asbestos exposure in Japan. Cancer Sci 103: 483-490, 2012.","DOI":"10.1111\/j.1349-7006.2011.02165.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Takeda K, Ohba H, Hyodo H, et al. Pericardial mesothelioma: hyaluronic acid in pericardial fluid. Am Heart J 110: 486-488, 1985.","DOI":"10.1016\/0002-8703(85)90175-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Butz T, Faber L, Langer C, et al. Primary malignant pericardial mesothelioma - a rare cause of pericardial effusion and consecutive constrictive pericarditis: a case report. J Med Case Rep 3: 9526, 2009.","DOI":"10.1186\/1752-1947-0003-0000009256"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. McGehee E, Gerber D, Reisch J, et al. Treatment and outcomes of primary pericardial mesothelioma: a contemporary review of 103. Clin Lung Cancer 20: 152-157, 2019.","DOI":"10.1016\/j.cllc.2018.11.008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chung CTS, Santos GDC, Hwang DM, et al. FISH assay development for the detection of p16\/CDKN2A deletion in malignant pleural mesothelioma. J Clin Pathol 63: 630-634, 2010.","DOI":"10.1136\/jcp.2010.076794"},{"key":"7","unstructured":"7. Kaul TK, Fields BL, Kahn DR. Primary malignant pericardial mesothelioma: a case report and review. J Cardiovasc Surg (Torino) 35: 261-267, 1994."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Arponen O, Salo V, L\u00f6nnberg A, et al. Primary pericardial mesothelioma: a case report of a patient treated with an immune checkpoint inhibitor as the second-line treatment. Acta Oncol 60: 687-691, 2021.","DOI":"10.1080\/0284186X.2021.1887515"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Baas P, Scherpereel A, Nowak AK, et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet 397: 375-386, 2021.","DOI":"10.1016\/S0140-6736(20)32714-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fujimoto N, Okada M, Kijima T, et al. Clinical efficacy and safety of nivolumab in Japanese patients with malignant pleural mesothelioma: 3-year results of the MERIT study. JTO Clin Res Rep 2: 100135, 2020.","DOI":"10.1016\/j.jtocrr.2020.100135"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Quispel-Janssen J, van der Noort V, de Vries JF, et al. Programmed death 1 blockade with nivolumab in patients with recurrent malignant pleural mesothelioma. J Thorac Oncol 13: 1569-1576, 2018.","DOI":"10.1016\/j.jtho.2018.05.038"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/4\/63_1707-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:30:54Z","timestamp":1715560254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/4\/63_1707-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1707-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"article-number":"1707-23"}}